Unraveling the NALP-3/IL-1beta inflammasome: a big lesson from a small mutation
- PMID: 15030767
- DOI: 10.1016/s1074-7613(04)00055-x
Unraveling the NALP-3/IL-1beta inflammasome: a big lesson from a small mutation
Abstract
Cytokine-mediated inflammation is a target for novel therapies as well as for fundamental research. A single amino acid mutation in the NALP-3 gene controlling the activation of caspase-1 results in increased processing of the inactive IL-1beta precursor and release of the active cytokine. Blocking IL-1 receptors arrests inflammation in humans with the mutation.
Comment on
-
NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder.Immunity. 2004 Mar;20(3):319-25. doi: 10.1016/s1074-7613(04)00046-9. Immunity. 2004. PMID: 15030775
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources